Log In
Print
BCIQ
Print
Print this Print this
 

ZPL-3893787 (formerly PF-03893787)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionHistamine H4 receptor (HR4R) antagonist
Molecular Target Histamine H4 receptor (HRH4) (H4)
Mechanism of ActionHistamine H4 receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis
Regulatory Designation
Partner Ziarco Group Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today